Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable, non-selective cation channel primarily expressed in small-diameter primary sensory neurons (nociceptors) of the dorsal root and trigeminal ganglia. It serves as a critical molecular sensor for noxious heat and is chemically activated by the neurosteroid pregnenolone sulfate. TRPM3 activation leads to cation influx, neuronal depolarization, and the release of calcitonin gene-related peptide (CGRP), which contributes to neurogenic inflammation and pain hypersensitivity. Recent research has identified TRPM3 as a key component of a novel pain-sensing pathway that is physiologically inhibited by G-protein-coupled receptors, such as the mu-opioid receptor, via the direct action of Gβγ subunits. This discovery positions TRPM3 as a promising therapeutic target for non-addictive analgesics, with several small-molecule inhibitors currently in development for inflammatory and neuropathic pain conditions.
TRPM3 is a non-selective cation channel that mediates the influx of calcium and sodium ions in response to noxious heat and chemical agonists like pregnenolone sulfate. Inhibition of this channel reduces the excitability of nociceptive neurons and the subsequent release of pro-inflammatory neuropeptides such as CGRP, thereby providing analgesic and anti-inflammatory effects.
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Transient receptor potential cation channel subfamily M member 3 (TRPM3) (TRPM3).